https://asia.nikkei.com/Business/Automobiles/Toyota-limits-orders-for-Lexus-in-Japan-due-to-chip-shortage
Benchmark Upgrades NeoGenomics to Buy, Maintains $20 Price Target
Benchmark analyst Bruce Jackson upgrades NeoGenomics (NASDAQ:NEO) from Hold to Buy and maintains $20 price target.